Literature DB >> 6202393

Malignant histiocytosis X. Report of a rapidly fatal case in an elderly man.

C Wood, G S Wood, D G Deneau, A Oseroff, J H Beckstead, J Malin.   

Abstract

A 71-year-old white man developed an increasing number of 1-to-10 mm, erythematous nodules, many with central ulceration, most prominent on the head and trunk. Biopsy of a nodule showed infiltration of the dermis and epidermis by large cells with multilobulated nuclei and numerous mitoses. Electron microscopy showed that most tumor cells contained Langerhans' cell granules. Immunohistochemical studies demonstrated a pattern of antigen expression similar to that of Langerhans' cells including Ia and Leu-6 (T6) antigens. Chest x-ray showed diffuse pulmonary infiltration and similar tumor cells were present in the sputum and urine. He developed increasing dyspnea and jaundice despite chemotherapy, and died 6 months after the onset of the disease. Autopsy showed massive tumor infiltration of the lungs, liver, spleen, and lymph nodes, and focal involvement of the myocardium, skin and bladder. Clinical and cytologic features indicated this case to be a rare example of highly malignant histiocytosis X in an elderly man.

Entities:  

Mesh:

Year:  1984        PMID: 6202393     DOI: 10.1002/1097-0142(19840715)54:2<347::aid-cncr2820540228>3.0.co;2-j

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  15 in total

1.  Pulmonary manifestation of a Langerhans cell sarcoma: case report and review of the literature.

Authors:  Boris Dominik Jülg; Sven Weidner; Doris Mayr
Journal:  Virchows Arch       Date:  2005-11-22       Impact factor: 4.064

2.  CD45 epitope mapping of human CD1a+ dendritic cells and peripheral blood dendritic cells.

Authors:  G S Wood; P S Freudenthal; A Edinger; R M Steinman; R A Warnke
Journal:  Am J Pathol       Date:  1991-06       Impact factor: 4.307

Review 3.  Cutaneous Langerhans cell sarcoma: a case report and review of the literature.

Authors:  Olga L Bohn; Guillermo Ruiz-Argüelles; Leticia Navarro; Jesus Saldivar; Sergio Sanchez-Sosa
Journal:  Int J Hematol       Date:  2007-02       Impact factor: 2.490

4.  CD56/NCAM-positive Langerhans cell sarcoma: a clinicopathologic study of 4 cases.

Authors:  Takakazu Kawase; Minoru Hamazaki; Michinori Ogura; Yoshiaki Kawase; Toshihiko Murayama; Yoshio Mori; Hirokazu Nagai; Masatoshi Tateno; Takashi Oyama; Yoshikazu Kamiya; Hirofumi Taji; Yoshitoyo Kagami; Tomoki Naoe; Toshitada Takahashi; Yasuo Morishima; Shigeo Nakamura
Journal:  Int J Hematol       Date:  2005-05       Impact factor: 2.490

5.  Case Report: Langerhans Cell Sarcoma With Intracranial and Extracranial Communication on the Left Frontal Bone.

Authors:  Shan Xie; Zhilin Shao; Dongqi Shao; Bang Du; Yi Han; Yu Li; Binbin Zhang; Xialin Zheng; Zhiquan Jiang
Journal:  Front Surg       Date:  2022-06-07

6.  Langerhans cell sarcoma arising from Langerhans cell histiocytosis: a case report.

Authors:  Jong-Sil Lee; Gyung Hyuck Ko; Ho Cheol Kim; In Seok Jang; Kyung-Nyeo Jeon; Jeong-Hee Lee
Journal:  J Korean Med Sci       Date:  2006-06       Impact factor: 2.153

7.  ESHAP therapy effective in a patient with Langerhans cell sarcoma.

Authors:  Akihide Yoshimi; Keiki Kumano; Toru Motokura; Yutaka Takazawa; Satoshi Oota; Shigeru Chiba; Tsuyoshi Takahashi; Masashi Fukayama; Mineo Kurokawa
Journal:  Int J Hematol       Date:  2008-04-17       Impact factor: 2.490

8.  Langerhans cell sarcoma arising from the root of tongue: a rare case.

Authors:  Jian-Jun Ren; Yu Zhao; Ming-Juan Liu; Guo Liu; Fei Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

9.  Prostate carcinoma metastatic to the skin as an extrammamary Paget's disease.

Authors:  Eugen Bogdan Petcu; Aldo Gonzalez-Serva; Robert G Wright; Mark Slevin; Klara Brinzaniuc
Journal:  Diagn Pathol       Date:  2012-08-18       Impact factor: 2.644

10.  Unusual cutaneous Langerhans cell sarcoma without extracutaneous involvement.

Authors:  Yang Li; Bin Li; Xiao-ying Tian; Zhi Li
Journal:  Diagn Pathol       Date:  2013-02-06       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.